Chemcel Biotech Ltd. - Research Center
533026 CHEMCEL Group (XT) BSE data
Results
Statement
More
Mar ' 11 |
Mar ' 10 |
Mar ' 09 |
Mar ' 08 |
Mar ' 07 |
Equity share capital
27.92 |
25.92 |
25.92 |
10.52 |
10.52 |
Share application money
Preference share capital
Reserves & surplus
15.52 |
14.66 |
13.13 |
2.79 |
1.56 |
Secured loans
Unsecured loans
Total
54.51 |
50.17 |
44.10 |
20.32 |
18.52 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
51.65 |
46.32 |
37.24 |
26.98 |
23.76 |
Less : current liabilities & provisions
Total net current assets
46.04 |
40.60 |
34.20 |
18.99 |
17.38 |
Miscellaneous expenses not written
Total
54.51 |
50.17 |
44.10 |
20.32 |
18.52 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
279.18 |
259.18 |
259.18 |
105.18 |
105.18 |